until the end of 2022, the first major pharmaceutical company, the Finnish Orion Pharma, will leave Russia. She began the liquidation of business, write Russian media.
The company ranked 90th among the largest pharmaceutical companies in Russia. She worked in the country for about 15 years. In 2021, the revenue of the OR amounted to 4.7 billion rubles, increasing by 45%. For the Finnish company, Russia is one of the largest markets. She had only 17% of global sales, or 44 million euros to Eastern Europe and Russia.
The company was engaged in the release of the drug “Metical Procedic”, which is used to treat rheumatoid arthritis, bronchial asthma, cancer and hepatitis. Since March, the company has stopped packaging the metrum at the Russian site “Pharmacor Production”.
ORION PHARMA Care will be the first case when a foreign pharmaceutical company leaves Russia.